Fulgent Genetics (FLGT) Non-Current Deferred Tax Liability (2016 - 2026)

Fulgent Genetics has disclosed Non-Current Deferred Tax Liability across 7 years of filings, most recently posting $7.0 million for Q1 2026.

• Non-Current Deferred Tax Liability for Q1 2026 came in at $7.0 million, up 11.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.0 million (up 11.94% YoY), and the FY2025 annual result was $6.9 million, up 8.89% from the prior year.
• Non-Current Deferred Tax Liability came in at $7.0 million for Q1 2026 at Fulgent Genetics, up from $6.9 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $9.8 million in Q3 2023 to a low of $6.1 million in Q2 2025.
• The 4-year median for Non-Current Deferred Tax Liability is $6.9 million (2024), against an average of $7.1 million.
• Across the five-year window, Non-Current Deferred Tax Liability tumbled 31.52% in 2024 and advanced 11.94% in 2026, its largest moves.
• Fulgent Genetics' Non-Current Deferred Tax Liability stood at $8.0 million in 2023, then retreated by 19.99% to $6.4 million in 2024, then advanced by 8.89% to $6.9 million in 2025, then rose by 0.66% to $7.0 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $7.0 million (Q1 2026), $6.9 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.